181 related articles for article (PubMed ID: 30917857)
1. Cause or effect? Interpreting emerging evidence for dysbiosis in systemic sclerosis.
Denton CP; Murray C
Arthritis Res Ther; 2019 Mar; 21(1):81. PubMed ID: 30917857
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement.
Patrone V; Puglisi E; Cardinali M; Schnitzler TS; Svegliati S; Festa A; Gabrielli A; Morelli L
Sci Rep; 2017 Nov; 7(1):14874. PubMed ID: 29093509
[TBL] [Abstract][Full Text] [Related]
3. Early-Life Antibiotic Exposure Causes Intestinal Dysbiosis and Exacerbates Skin and Lung Pathology in Experimental Systemic Sclerosis.
Mehta H; Goulet PO; Mashiko S; Desjardins J; Pérez G; Koenig M; Senécal JL; Constante M; Santos MM; Sarfati M
J Invest Dermatol; 2017 Nov; 137(11):2316-2325. PubMed ID: 28757138
[TBL] [Abstract][Full Text] [Related]
4. Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease.
Andréasson K; Alrawi Z; Persson A; Jönsson G; Marsal J
Arthritis Res Ther; 2016 Nov; 18(1):278. PubMed ID: 27894337
[TBL] [Abstract][Full Text] [Related]
5. Dysbiosis and Gut Microbiota Modulation in Systemic Sclerosis.
Lemos MPC; Zucoloto TG; Oliveira MC; de Oliveira GLV
J Clin Rheumatol; 2022 Mar; 28(2):e568-e573. PubMed ID: 34030162
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status.
Natalello G; Bosello SL; Paroni Sterbini F; Posteraro B; De Lorenzis E; Canestrari GB; Gigante L; Verardi L; Ferraccioli G; Sanguinetti M; Gremese E
Clin Exp Rheumatol; 2020; 38 Suppl 125(3):73-84. PubMed ID: 32865168
[TBL] [Abstract][Full Text] [Related]
7. Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin.
Johnson ME; Franks JM; Cai G; Mehta BK; Wood TA; Archambault K; Pioli PA; Simms RW; Orzechowski N; Arron S; Whitfield ML
Arthritis Res Ther; 2019 Feb; 21(1):49. PubMed ID: 30728065
[TBL] [Abstract][Full Text] [Related]
8. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
9. The Microbiome in Systemic Sclerosis: Pathophysiology and Therapeutic Potential.
Kim S; Park HJ; Lee SI
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555792
[TBL] [Abstract][Full Text] [Related]
10. A review and roadmap of the skin, lung and gut microbiota in systemic sclerosis.
Teaw S; Hinchcliff M; Cheng M
Rheumatology (Oxford); 2021 Dec; 60(12):5498-5508. PubMed ID: 33734316
[TBL] [Abstract][Full Text] [Related]
11. The possible mechanisms of the human microbiome in allergic diseases.
Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
[TBL] [Abstract][Full Text] [Related]
12. Update on the Gastrointestinal Microbiome in Systemic Sclerosis.
Bellocchi C; Volkmann ER
Curr Rheumatol Rep; 2018 Jun; 20(8):49. PubMed ID: 29943234
[TBL] [Abstract][Full Text] [Related]
13. The potential of fecal microbiota transplantation in systemic sclerosis.
Hoffmann-Vold AM; Fretheim H; Didriksen H; Molberg Ø
Expert Rev Clin Immunol; 2020 Feb; 16(2):117-118. PubMed ID: 31858856
[No Abstract] [Full Text] [Related]
14. The role of gut microbiota in the pathogenesis of rheumatic diseases.
Zhong D; Wu C; Zeng X; Wang Q
Clin Rheumatol; 2018 Jan; 37(1):25-34. PubMed ID: 28914372
[TBL] [Abstract][Full Text] [Related]
15. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
16. Intestinal microbiome in scleroderma: recent progress.
Volkmann ER
Curr Opin Rheumatol; 2017 Nov; 29(6):553-560. PubMed ID: 28719392
[TBL] [Abstract][Full Text] [Related]
17. Bacterial Dysbiosis and Translocation in Psoriasis Vulgaris.
Visser MJE; Kell DB; Pretorius E
Front Cell Infect Microbiol; 2019; 9():7. PubMed ID: 30778377
[TBL] [Abstract][Full Text] [Related]
18. Proteobacteria: microbial signature of dysbiosis in gut microbiota.
Shin NR; Whon TW; Bae JW
Trends Biotechnol; 2015 Sep; 33(9):496-503. PubMed ID: 26210164
[TBL] [Abstract][Full Text] [Related]
19. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.
Chen B; Sun L; Zhang X
J Autoimmun; 2017 Sep; 83():31-42. PubMed ID: 28342734
[TBL] [Abstract][Full Text] [Related]
20. A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.
Taroni JN; Greene CS; Martyanov V; Wood TA; Christmann RB; Farber HW; Lafyatis RA; Denton CP; Hinchcliff ME; Pioli PA; Mahoney JM; Whitfield ML
Genome Med; 2017 Mar; 9(1):27. PubMed ID: 28330499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
